Josh Knowles

Assistant Professor

Stanford University
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Josh Knowles is an Assistant Professor at Stanford University in the United States. His research interests include lipoprotein metabolism, longevity and insulin sensitivity, and the effects of dietary interventions on health outcomes. His recent publications focus on diverse topics such as lipid disorders, cardiovascular fellowship applicant diversity, and the implications of neurodevelopmental factors in schizophrenia.

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

The study of neurodevelopmental molecular mechanisms in schizophrenia requires the development of adequate biological models such as patient-derived cells and their derivatives. We previously utilized cell lines with neural progenitor properties (CNON) derived from the superior or middle turbinates of patients with schizophrenia and control groups to study schizophrenia-specific gene expression. In this study, we analyzed single-cell RNA seq data from two CNON cell lines (one derived from an individual with schizophrenia (SCZ) and the other from a control group) and two biopsy samples from the middle turbinate (MT) (also from an individual with SCZ and a control). We compared our data with previously published data regarding the olfactory neuroepithelium and demonstrated that CNON originated from a single cell type present both in middle turbinate and the olfactory neuroepithelium and expressed in multiple markers of mesenchymal cells. To define the relatedness of CNON to the developing human brain, we also compared CNON datasets with scRNA-seq data derived from an embryonic brain and found that the expression profile of the CNON closely matched the expression profile one of the cell types in the embryonic brain. Finally, we evaluated the differences between SCZ and control samples to assess the utility and potential benefits of using CNON single-cell RNA seq to study the etiology of schizophrenia.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Christopher ODonnell

VP, Global Head, Cardiovascular and Metabolism Translational Medicine

Novartis

SWITZERLAND
View details

Summer Ngo

Stanford University School of Medicine

UNITED STATES
View details

Oleg V. Evgrafov

-

UNITED STATES
View details

Nadine Nagy

Stanford University

UNITED STATES
View details

Pankaj Arora

Associate Professor

The University of Alabama

UNITED STATES
View details

Thomas Martin

Assistant Clinical Professor

UCSD

UNITED STATES
View details

Cynthia Monaco

Assistant Professor

University of Rochester Medical Center

UNITED STATES
View details

Timothy Hatlen

The Lundquist Institute

UNITED STATES
View details

Jenny Hendriks

Head Biomarkers

Janssen (Netherlands)

NETHERLANDS
View details

Paul Kilgore

Associate Professor

Wayne State University

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.